BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/13/2018 7:26:52 AM | Browse: 1054 | Download: 1220
 |
Received |
|
2018-08-27 01:28 |
|
Peer-Review Started |
|
2018-08-27 01:55 |
|
To Make the First Decision |
|
2018-10-08 07:41 |
|
Return for Revision |
|
2018-10-09 01:24 |
|
Revised |
|
2018-10-24 22:41 |
|
Second Decision |
|
2018-11-23 11:02 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-11-26 16:46 |
|
Articles in Press |
|
2018-11-26 16:46 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-12-07 06:53 |
|
Publish the Manuscript Online |
|
2018-12-13 07:26 |
| ISSN |
2150-5349 (online) |
| Open Access |
There have been tremendous changes in the treatment of acid-related diseases. In this rapidly evolving field, novel drugs such as potassium-competitive acid blockers (P-CABs) show promising potential. This review aims to provide a perspective on this new class of drugs by summarizing the mechanism of action, therapeutic benefits, adverse effects and approval status of various P-CABs in the market. |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Potassium-competitive acid blockers – are they the next generation of proton pump inhibitors?
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Prashanth Rawla, Tagore Sunkara, Andrew Ofosu and Vinaya Gaduputi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Prashanth Rawla, MD, Doctor, Staff Physician, Department of Internal Medicine/Hospitalist, SOVAH Health, 320 Hospital Dr, Martinsville, VA 24112, United States. rawlap@gmail.com |
| Key Words |
Potassium-competitive acid blockers; Gastroesophageal reflux disease; Proton pump inhibitors; Peptic ulcer disease; Vonoprazan |
| Core Tip |
There have been tremendous changes in the treatment of acid-related diseases. In this rapidly evolving field, novel drugs such as potassium-competitive acid blockers (P-CABs) show promising potential. This review aims to provide a perspective on this new class of drugs by summarizing the mechanism of action, therapeutic benefits, adverse effects and approval status of various P-CABs in the market. |
| Publish Date |
2018-12-13 07:26 |
| Citation |
Rawla P, Sunkara T, Ofosu A, Gaduputi V. Potassium-competitive acid blockers – are they the next generation of proton pump inhibitors? World J Gastrointest Pharmacol Ther 2018; 9(7): 63-68 |
| URL |
https://www.wjgnet.com/2150-5349/full/v9/i7/63.htm |
| DOI |
https://dx.doi.org/10.4292/wjgpt.v9.i7.63 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
